CCL22 and Alzheimer disease: A characteristic microbiome signature has often been described for AD and this pattern was recently shown to associate with the expression of type 2 inflammation pathway genes such as IL-4R, C-C motif chemokine receptor type 4 (CCR4), and C- C motif chemokine 22 (CCL22) in lesional compared with non-lesional skin [51].